These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice. Karler R; Turkanis SA Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593 [TBL] [Abstract][Full Text] [Related]
23. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol. Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703 [TBL] [Abstract][Full Text] [Related]
24. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Zuardi AW; Shirakawa I; Finkelfarb E; Karniol IG Psychopharmacology (Berl); 1982; 76(3):245-50. PubMed ID: 6285406 [TBL] [Abstract][Full Text] [Related]
25. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
26. Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). Rock EM; Parker LA Behav Neurosci; 2015 Jun; 129(3):368-70. PubMed ID: 26030435 [TBL] [Abstract][Full Text] [Related]
27. delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters. van Ree JM; Niesink RJ; Nir I Psychopharmacology (Berl); 1984; 84(4):561-5. PubMed ID: 6098915 [TBL] [Abstract][Full Text] [Related]
28. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol. Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921 [TBL] [Abstract][Full Text] [Related]
29. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite. Spanagel R; Bilbao A Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977 [TBL] [Abstract][Full Text] [Related]
31. Effect of prior foot shock stress and Δ Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834 [TBL] [Abstract][Full Text] [Related]
32. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus. Lindamood C; Colasanti BK J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205 [TBL] [Abstract][Full Text] [Related]
33. Cannabinoid modulation of functional connectivity within regions processing attentional salience. Bhattacharyya S; Falkenberg I; Martin-Santos R; Atakan Z; Crippa JA; Giampietro V; Brammer M; McGuire P Neuropsychopharmacology; 2015 May; 40(6):1343-52. PubMed ID: 25249057 [TBL] [Abstract][Full Text] [Related]
34. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839 [TBL] [Abstract][Full Text] [Related]
36. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187 [TBL] [Abstract][Full Text] [Related]
37. The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve. James TR; Watson CT; Pepple DJ Fitoterapia; 2020 Jun; 143():104539. PubMed ID: 32147492 [TBL] [Abstract][Full Text] [Related]
38. Female but not male rats show biphasic effects of low doses of Δ Salviato BZ; Raymundi AM; Rodrigues da Silva T; Salemme BW; Batista Sohn JM; Araújo FS; Guimarães FS; Bertoglio LJ; Stern CA Neuropharmacology; 2021 Sep; 196():108684. PubMed ID: 34181978 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303 [TBL] [Abstract][Full Text] [Related]
40. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. Hillard CJ; Harris RA; Bloom AS J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]